AR030378A1 - Empleo de triazintrion-sulfonas para la lucha contra la coccidiosis - Google Patents

Empleo de triazintrion-sulfonas para la lucha contra la coccidiosis

Info

Publication number
AR030378A1
AR030378A1 ARP010103948A ARP010103948A AR030378A1 AR 030378 A1 AR030378 A1 AR 030378A1 AR P010103948 A ARP010103948 A AR P010103948A AR P010103948 A ARP010103948 A AR P010103948A AR 030378 A1 AR030378 A1 AR 030378A1
Authority
AR
Argentina
Prior art keywords
triazintrion
sulphones
employment
fight against
against coccidiosis
Prior art date
Application number
ARP010103948A
Other languages
English (en)
Spanish (es)
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of AR030378A1 publication Critical patent/AR030378A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/30—Only oxygen atoms
    • C07D251/34—Cyanuric or isocyanuric esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
ARP010103948A 2000-08-17 2001-08-17 Empleo de triazintrion-sulfonas para la lucha contra la coccidiosis AR030378A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10040174A DE10040174A1 (de) 2000-08-17 2000-08-17 Verwendung von Triazintrion-Sulfonen zur Bekämpfung von Coccidiosen

Publications (1)

Publication Number Publication Date
AR030378A1 true AR030378A1 (es) 2003-08-20

Family

ID=7652719

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010103948A AR030378A1 (es) 2000-08-17 2001-08-17 Empleo de triazintrion-sulfonas para la lucha contra la coccidiosis

Country Status (23)

Country Link
US (1) US7915257B2 (enExample)
EP (1) EP1311491A1 (enExample)
JP (1) JP2004506624A (enExample)
KR (1) KR100803078B1 (enExample)
CN (3) CN101361743A (enExample)
AR (1) AR030378A1 (enExample)
AU (2) AU2001278522B2 (enExample)
BR (1) BR0113268A (enExample)
CA (1) CA2419471C (enExample)
CZ (1) CZ300020B6 (enExample)
DE (1) DE10040174A1 (enExample)
HR (1) HRP20030194A2 (enExample)
HU (1) HUP0303701A3 (enExample)
MX (1) MXPA03001429A (enExample)
MY (1) MY136518A (enExample)
NO (1) NO20030585D0 (enExample)
NZ (1) NZ524200A (enExample)
PL (1) PL359709A1 (enExample)
SK (1) SK1652003A3 (enExample)
TW (1) TW200819431A (enExample)
WO (1) WO2002014288A1 (enExample)
YU (1) YU11703A (enExample)
ZA (1) ZA200301225B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004001558A1 (de) * 2004-01-10 2005-08-18 Bayer Healthcare Ag Arzneimittel zur topischen Applikation bei Tieren
DE102006038292A1 (de) * 2006-08-16 2008-02-21 Bayer Healthcare Ag Transdermale Anwendung von Triazinen zur Bekämpfung von Coccidien-Infektionen
DE102007025908A1 (de) * 2007-06-01 2008-12-04 Bayer Healthcare Ag Formulierungen enthaltend Triazinone und Eisen
SI22751A (sl) 2008-04-03 2009-10-31 Krka, D.D., Novo Mesto Toltrazuril z izboljĺ animi lastnostmi za raztapljanje
DE102009012423A1 (de) 2009-03-10 2010-09-16 Bayer Animal Health Gmbh Zubereitung auf Ölbasis
EP2740492A1 (en) 2012-12-07 2014-06-11 Ceva Sante Animale Triazine formulations with a second active ingredient and surfactant(s)
EP2740469A1 (en) * 2012-12-07 2014-06-11 Ceva Sante Animale New treatments with triazines
EP2740470A1 (en) * 2012-12-07 2014-06-11 Ceva Sante Animale Treatment of Coccidiosis with intramuscular triazine composition
CN102973497A (zh) * 2012-12-13 2013-03-20 江苏恒丰强生物技术有限公司 一种托曲珠利溶液及其制备方法
US11352332B2 (en) 2018-02-26 2022-06-07 AlzeCure Pharma AB Triazine derivatives for treating diseases relating to neurotrophins
EP3578181A1 (en) 2018-06-05 2019-12-11 Bayer Animal Health GmbH Formulation for use in the simultaneous treatment of coccidial infections and iron deficiencies
GB201810668D0 (en) 2018-06-28 2018-08-15 Stiftelsen Alzecure New compounds
JP7825401B2 (ja) * 2021-09-30 2026-03-06 株式会社ジーシーR&D 主材ペースト、及び歯科用アルギン酸塩印象材

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2413722C3 (de) 1974-03-21 1982-04-08 Bayer Ag, 5090 Leverkusen Neue 1-(4-Phenoxy-phenyl)-1,3,5-triazin-Derivate, ein Verfahren zu ihrer Herstellung sowie ihre Anwendung als Arzneimittel
DE2414612A1 (de) 1974-03-26 1975-10-16 Bayer Ag 1-aryluracile, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2532363A1 (de) 1975-07-19 1977-02-03 Bayer Ag Substituierte 2-phenyl-1,2,4- triazin-3,5(2h,4h)-dione, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2718799A1 (de) 1977-04-27 1978-11-09 Bayer Ag 1-(4-phenoxy-phenyl)-1,3,5-triazin- derivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel und wachstumsfoerderer
US4255231A (en) * 1979-06-13 1981-03-10 Congoleum Corporation Carpet etching
DE3314739A1 (de) * 1983-04-23 1984-10-25 Bayer Ag, 5090 Leverkusen 1-(4-(4-(fluoralkylmethylthio- oder -sulfinyl- oder -sulfonyl-)phenoxy) phenyl)-1,3,5-triazin-2,4,6(1h,3h,5h)-trione, verfahren zu ihrer herstellung und ihre verwendung als coccidiosemittel
US4837029A (en) * 1987-04-06 1989-06-06 Carolina Medical Products, Inc. Low foaming, aqueously homogenizable rifampin composition
US4808404A (en) * 1988-01-11 1989-02-28 A. H. Robins Company, Inc. Live vaccine for coccidiosis utilizing coccidial sporozoites
DE19824483A1 (de) 1998-06-02 1999-12-09 Bayer Ag Halbfeste wäßrige Zubereitungen für orale Applikation von Toltrazuril-Sulfon
HK1043019B (zh) 1998-10-08 2005-05-13 高新研究公司 用於预防和治疗原虫病的组合物和方法
US6150361A (en) * 1998-12-22 2000-11-21 Bayer Corporation Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma
HUP0104716A3 (en) * 1998-12-22 2003-10-28 Bayer Corp Pittsburgh Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma and medicaments containing them

Also Published As

Publication number Publication date
US7915257B2 (en) 2011-03-29
KR100803078B1 (ko) 2008-02-18
AU2001278522B9 (en) 2002-02-25
KR20030017659A (ko) 2003-03-03
NZ524200A (en) 2005-02-25
YU11703A (sh) 2006-01-16
US20040013699A1 (en) 2004-01-22
NO20030585L (no) 2003-02-06
DE10040174A1 (de) 2002-02-28
MY136518A (en) 2008-10-31
CZ300020B6 (cs) 2009-01-14
CN101361743A (zh) 2009-02-11
HUP0303701A3 (en) 2006-01-30
SK1652003A3 (en) 2004-02-03
PL359709A1 (en) 2004-09-06
AU2001278522B2 (en) 2007-03-22
EP1311491A1 (de) 2003-05-21
CA2419471A1 (en) 2003-02-14
ZA200301225B (en) 2004-02-16
HRP20030194A2 (en) 2005-10-31
CN1853635A (zh) 2006-11-01
BR0113268A (pt) 2003-07-08
NO20030585D0 (no) 2003-02-06
MXPA03001429A (es) 2004-05-04
CN1469868A (zh) 2004-01-21
CA2419471C (en) 2009-10-13
AU7852201A (en) 2002-02-25
WO2002014288A1 (de) 2002-02-21
TW200819431A (en) 2008-05-01
JP2004506624A (ja) 2004-03-04
HUP0303701A2 (hu) 2004-03-29

Similar Documents

Publication Publication Date Title
BR0113798A (pt) Derivados de resorcinol
ES2192301T3 (es) Derivados de resorcinol.
HN2001000190A (es) Formulaciones de liberacion sostenida para secretagogos de hormona del crecimiento
HN2001000027A (es) Derivados de purina
EP1539122A4 (en) PHARMACEUTICAL AQUEOUS 2,6-DIISOPROPYLPHENOL COMPOSITIONS
BR0114799A (pt) Compostos de ácido cianofenoxi carboxìlico e composições para liberar agentes ativos
ES2421948T3 (es) Compuestos y composiciones para suministrar agentes activos
UY26269A1 (es) Formulación de sal común y moxifloxacina
WO2002024613A3 (en) Resorcinol derivatives
BR0114903A (pt) 7-azaindóis, sua aplicação como inibidores da fosfodiesterase 4 e processos para a sua preparação
MXPA03001429A (es) Uso de triazintrion-sulfonas para la lucha contra la coccidiosis.
GT200400257A (es) Composicion herbicida
PL369304A1 (en) Toilet bar having a latent acidifier
YU60101A (sh) Derivati rezorcinola
ATE417915T1 (de) Reinigungsaktive und desinfizierende zusammensetzung
GT200200094A (es) Microcapsulas para la proteccion frente al mal aliento
PA8492001A1 (es) Composicion de resorcinol
AU2001285944A1 (en) Fungicidal agent containing n-chlorotaurine and use thereof
HN2000000090A (es) Sal difosfato de un derivado de 4sustituido-9-desoxo-9a-aza-9a-homoeritromicina y su composicion farmaceutica.
MY141606A (en) N-alkoxyalkyl-substituted benzimidazoles, their preparation and their use as agents against parasitic protozoa
MXPA05012500A (es) Agentes depigmentantes.
BR0113294A (pt) Aplicação de triazintrion-sulfóxidos para comebater coccidioses
HN1999000115A (es) Derivados de imidoamida.
GT200000008A (es) Pirazolalquilamidas
MXPA05008107A (es) Agentes de despigmentacion.

Legal Events

Date Code Title Description
FB Suspension of granting procedure